Phenotypic modulation of alveolar myofibroblasts in transplanted human lungs

Modern Pathology

Volumn 10, Issue 11, 1997, Pages 1134-1142

  Kapanci, Yusuf ^a   Kurt, Anne Marie ^a   Redard, Mireille ^a   Gabbiani, Giulio ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

SMA; Acute rejection; Alveolar myofibroblasts; Lung transplantation; Pulmonary fibrosis; TGF 1; TNF

Indexed keywords

ALPHA ACTIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; EMPHYSEMA; FEMALE; GRAFT REJECTION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL; LUNG BIOPSY; LUNG DISEASE; LUNG FIBROSIS; LUNG TRANSPLANTATION; MALE; MYOFIBROBLAST; PHENOTYPE; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; ANTIGENS, CD; BIOPSY; CYTOSKELETAL PROTEINS; FEMALE; FIBROBLASTS; GRAFT REJECTION; HLA-DR ANTIGENS; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PHENOTYPE; PULMONARY ALVEOLI; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030726792     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Yousem S. A perspective on the revised working formulation for grading of lung allograft rejection. Transplant Proc 1996; 28:477-9.
2. Yousem SA, Berry GJ, Brunt EM, Chamberlain D, Hruban RH, Sibley RK, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: lung rejection study group. J Heart Transplant 1990;9:593-601.
3. Piguet PF, Grau GE, Collart MA, Vassalli P, Kapanci Y. Pneumopathies of the graft-versus-host reaction. Alveolitis associated with an increased level of tumor necrosis factor mRNA and chronic interstitial pneumonitis. Lab Invest 1989; 61:37-45.
4. Saito R, Prehn I, Zuo XJ, Marchevesky A, Castracane J, Waters P, et al. The participation of tumor necrosis factor in the pathogenesis of lung allograft rejection in the rat. Transplantation 1993;55:967-72.
5. Serrick C, Adoumie R, Giaid A, Shennib H. The early release of interleukin-2, tumor necrosis factor-α, and interferon-γ after ischemia reperfusion injury in the lung allograft. Transplantation 1994;58:1158-62.
6. Desmoulière A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factor-β1 induces a-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993;122: 103-11.
7. Kapanci Y, Desmoulière A, Pache JC, Redard M, Gabbiani G. Cytoskeletal protein modulation in pulmonary alveolar myofibroblasts during idiopathic pulmonary fibrosis. Possible role of transforming growth factor-β and tumor necrosis factor-α. Am J Respir Crit Care Med 1995;152:2163-9.
8. Kapanci Y, Gabbiani G. Physiological and pathological features of contractile cells in pulmonary alveolar tissue. In: Crystal RG, West JB, editors. The lung: scientific foundation. 2nd ed. New York: Lippincott-Raven; 1997. p. 697-707.
9. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G. A monoclonal antibody against α-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol 1986;103:2787-96.
10. Skalli O, Vandekerckhove J, Gabbiani G. Actin isoform pattern as marker of normal or pathological smooth muscle and fibroblastic tissues. Differentiation 1987;33:232-8.
11. Perdue TD, Brody AR. Distribution of transforming growth factor-β1, fibronectin, and smooth muscle actin in asbestos-induced pulmonary fibrosis in rats. J Histochem Cytochem 1994;42:1061-70.
12. Piguet P-F, Ribaux C, Karpuz V, Grau GE, Kapanci Y. Expression and localization of tumor necrosis factor-α and its mRNA in idiopathic pulmonary fibrosis. Am J Pathol 1993; 143:651-5.
13. Skalli O, Schürch W, Seemayer T, Lagacé R, Montandon D, Pittet B, et al. Myofibroblasts from diverse pathological settings are heterogeneous in their content of actin isoforms and intermediate filament proteins. Lab Invest 1989;60:275-85.
14. Kapanci Y, Ribaux C, Chaponnier C, Gabbiani G. Cytoskeletal features of alveolar myofibroblasts and pericytes in normal human and rat lung. J Histochem Cytochem 1992;40: 1955-63.
15. Leslie KO, Mitchell J, Low R. Lung myofibroblasts. Cell Motil Cytoskeleton 1992;22:92-8.
16. Vyalov SL, Gabbiani G, Kapanci Y. Rat alveolar myofibroblasts acquire α-smooth muscle actin expression during bleomycin-induced pulmonary fibrosis. Am J Pathol 1993; 143:1754-65.
17. Adler KB, Low RB, Leslie KO, Mitchell J, Evans JN. Biology of disease. Contractile cells in normal and fibrotic lung. Lab Invest 1989;60:473-85.
18. Mitchell JJ, Woodcock-Mitchell J, Reynolds S, Low R, Leslie K, Adler K, et al. α-smooth muscle actin in parenchymal cells of bleomycin-injured rat lung. Lab Invest 1989;60:643-50.
19. Mariani TJ, Roby JD, Mecham RP, Parks WC, Crouch E, Pierce RA. Localization of type I procollagen gene expression in silica-induced granulomatous lung disease and implication of transforming growth factor-β as a mediator of fibrosis. Am J Pathol 1996;148:151-64.
20. Zhang K, Rekhter MD, Gordon D, Phan SH. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am J Pathol 1994;145:114-25.
21. Kuhn Ch, McDonald JA. The role of myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am J Pathol 1991;138:1257-65.
22. Desmoulière A, Gabbiani G. The role of the myofibroblast in wound healing and fibrocontractive diseases. In: Clark RAF, editor. The molecular and cellular biology of wound repair. New York: Plenum Press; 1996. p. 391-423.
23. Nash JR, McLaughlin PJ, Butcher D, Corrin B. Expression of tumour necrosis factor-α in cryptogenic fibrosing alveolitis. Histopathology 1993;22:343-7.
24. Corrin B, Butcher D, McAnulty BJ, Dubois RM, Black CM, Laurent GJ, et al. Immunohistochemical localization of transforming growth factor-β1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders. Histopathology 1994;24:145-50.
25. Khalil N, O'Connor RN, Flanders KC, Unruh H. TGF-β1, but not TGF-β2 or TFG-β3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study. Am J Respir Cell Mol Biol 1996;14:131-48.
26. Khalil N, O'Connor RN, Unruh HW, Warren PW, Flanders KC, Kemp A, et al. Increased production and immunohistochemical localization of transforming growth factor-β in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 1991; 5:155-62.
27. Serini G, Gabbiani G. Modulation of α-smooth muscle actin expression in fibroblasts by transforming growth factor-β isoforms: an in vivo and in vitro study. Wound Rep Reg 1996;4:277-87.
28. Shah M, Foreman DM, Ferguson MWJ. Neutralization of TGF-β1 and TGF-β2 or exogenous addition of TGF-β3 to cutaneous rat wounds reduces scarring. J Cell Sci 1995;108: 985-1002.
29. Desmoulière A, Gabbiani G. Modulation of fibroblastic cytoskeletal features during pathological situations: the role of extracellular matrix and cytokines. Cell Motil Cytoskeleton 1994;29:195-203.
30. Zhang H, Gharaee-Kermani M, Zhang K, Karmiol S, Phan SH. Lung fibroblast α-smooth muscle actin expression and contractile phenotype in bleomycin-induced pulmonary fibrosis. Am J Pathol 1996;148:527-37.
31. Beutler B, Cerami A. Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu Rev Biochem 1988;57:505-18.
32. Cuturi MC, Murphy M, Costa-Giomi MP, Weinmann R, Perussia B, Trinchieri G. Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. J Exp Med 1987;165:1581-94.
33. Gauldie I, Jordana M, Cox G. Cytokines and pulmonary fibrosis. Thorax 1993;48:931-5.
34. Sheppard MN, Harrison NK. New perspectives on basic mechanisms in lung disease. I. Lung injury, inflammatory mediators, and fibroblast activation in fibrosing alveolitis. Thorax 1992;47:1064-74.
35. Darby I, Saklli O, Gabbiani G. α-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 1990;63:21-9.
36. Desmoulière A, Redard M, Darby I, Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995;146:56-66.